Li, Deying
Zalesky, Andrew https://orcid.org/0000-0003-2298-9908
Wang, Yufan
Wang, Haiyan
Ma, Liang
Cheng, Luqi
Banaschewski, Tobias https://orcid.org/0000-0003-4595-1144
Barker, Gareth J. https://orcid.org/0000-0002-5214-7421
Bokde, Arun L. W. https://orcid.org/0000-0003-0114-4914
Brühl, Rüdiger https://orcid.org/0000-0003-0111-5996
Desrivières, Sylvane https://orcid.org/0000-0002-9120-7060
Flor, Herta https://orcid.org/0000-0003-4809-5398
Garavan, Hugh https://orcid.org/0000-0002-8939-1014
Gowland, Penny https://orcid.org/0000-0002-4900-4817
Grigis, Antoine
Heinz, Andreas https://orcid.org/0000-0001-5405-9065
Lemaître, Hervé https://orcid.org/0000-0002-5952-076X
Martinot, Jean-Luc https://orcid.org/0000-0002-0136-0388
Martinot, Marie-Laure Paillère
Artiges, Eric https://orcid.org/0000-0003-4461-7646
Nees, Frauke https://orcid.org/0000-0002-7796-8234
Orfanos, Dimitri Papadopoulos https://orcid.org/0000-0002-1242-8990
Poustka, Luise
Smolka, Michael N. https://orcid.org/0000-0001-5398-5569
Vaidya, Nilakshi https://orcid.org/0000-0002-4600-7158
Walter, Henrik https://orcid.org/0000-0002-9403-6121
Whelan, Robert https://orcid.org/0000-0002-2790-7281
Schumann, Gunter https://orcid.org/0000-0002-7740-6469
Jia, Tianye https://orcid.org/0000-0001-5399-2953
Chu, Congying https://orcid.org/0000-0002-7808-8896
Fan, Lingzhong https://orcid.org/0000-0002-4813-621X
,
Article History
Received: 22 April 2025
Accepted: 30 July 2025
First Online: 12 August 2025
Competing interests
: Dr Banaschewski served in an advisory or consultancy role for Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Shire. He received conference support or speaker’s fee by Lilly, Medice, Novartis, and Shire. He has been involved in clinical trials conducted by Shire & Viforpharma. He received royalties from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press. The present work is unrelated to the above grants and relationships. Dr Barker has received honoraria from General Electric Healthcare for teaching on scanner programming courses. Dr Poustka served in an advisory or consultancy role for Roche and Viforpharm and received speaker’s fee by Shire. She received royalties from Hogrefe, Kohlhammer, and Schattauer. The present work is unrelated to the above grants and relationships. The other authors report no biomedical financial interests or potential conflicts of interest.